Paolo Tarantino
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Paolo Tarantino
May 14, 2024, 03:26 |
Blog
Top 10 Abstracts at ESMO Breast 24 by Paolo Tarantino
Paolo Tarantino made the following post on LinkedIn: "Less than 48h to ESMO Breast 24:…
May 14, 2024, 03:07 |
Blog
Erika Hamilton: Fantastic list for ESMO Breast 24
Erika Hamilton shared a post by Paolo Tarantino on LinkedIn, adding: "Fantastic list for ESMO Breast 24.…
May 13, 2024, 12:54 |
Blog
Become part of the conversation about the science presented at ESMO Breast24
European Society for Medical Oncology shared on their X page: "Do not miss the latest…
May 13, 2024, 07:12 |
Blog
Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano
Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…
May 11, 2024, 11:39 |
Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 11, 2024, 11:23 |
Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
May 7, 2024, 23:29 |
Blog
Paolo Tarantino: Thanks to all the people for making Med Twitter a very special place!
Paolo Tarantino shared a previous post of him on X and added: “3 more years, same…
May 4, 2024, 10:27 |
Insight
Paolo Tarantino: HER2 is about to change again
Paolo Tarantino shared a previous post of him on X and added: "HER2 is about…
May 3, 2024, 16:17 |
Blog
Paolo Tarantino: HER2-low: should we even test?
Paolo Tarantino shared a post on X: "The timing couldn’t be more appropriate for this…
May 2, 2024, 15:20 |
Blog
Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years
Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…
1
2
3
4
5
All:
115
Posts:
11 - 20
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube